E-LIB Suche - Ergebnisse für: Lovász, Barbara D.

1

Comparison of Efficacy and Safety of Commercially Available..:

Visolyi, Gergely Á. ; Domján, Beatrix A. ; Svébis, Márk M....
Canadian Journal of Diabetes. 47 (2023) 4 - p. 368-377 , 2023

Link: https://doi.org/10.1016/..

2

Clinical efficacy, drug sustainability and serum drug level..:

Gonczi, Lorant ; Szanto, Kata ; Farkas, Klaudia...
Digestive and Liver Disease. 54 (2022) 2 - p. 207-213 , 2022

Link: https://doi.org/10.1016/..

3

Therapeutic preferences and outcomes in newly diagnosed pat..:

Kurti, Zsuzsanna ; Ilias, Akos ; Gonczi, Lorant...
BMC Gastroenterology. 18 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

4

Drug persistence and need for dose intensification to adali..:

Gonczi, Lorant ; Kurti, Zsuzsanna ; Rutka, Mariann...
BMC Gastroenterology. 17 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

5

Long-term Efficacy, Safety, and Immunogenicity of Biosimila..:

Gonczi, Lorant ; Gecse, Krisztina B. ; Vegh, Zsuzsanna...
Inflammatory Bowel Diseases. 23 (2017) 11 - p. 1908-1915 , 2017

Link: https://doi.org/10.1097/..

6

Nationwide prevalence and drug treatment practices of infla..:

Kurti, Zsuzsanna ; Vegh, Zsuzsanna ; Golovics, Petra A....
Digestive and Liver Disease. 48 (2016) 11 - p. 1302-1307 , 2016

Link: https://doi.org/10.1016/..

7

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy ..:

Farkas, Klaudia ; Rutka, Mariann ; Golovics, Petra A....
Journal of Crohn's and Colitis. 10 (2016) 11 - p. 1273-1278 , 2016

Link: https://doi.org/10.1093/..

8

Perceived Risks Contra Benefits of Using Biosimilar Drugs i..:

Baji, Petra ; Gulácsi, László ; Golovics, Petra A....
Value in Health Regional Issues. 10 (2016) - p. 85-90 , 2016

Link: https://doi.org/10.1016/..

9

Does Hospitalization Predict the Disease Course in Ulcerati..:

Lakatos, Peter L. ; Pandur, Tunde ; Balogh, Mihaly...
Journal of Gastrointestinal and Liver Diseases. 24 (2015) 3 - p. 287-292 , 2015

Link: https://doi.org/10.15403..

10

Sa1156 Accelerated Treatment Strategy in Inflammatory Bowel..:

Golovics, Petra A. ; Farkas, Klaudia ; Sipeki, Nora...
Gastroenterology. 148 (2015) 4 - p. S-242-S-243 , 2015

Link: https://doi.org/10.1016/..

11

Sa1157 Presence of Anaemia Is an Indicator of Long-Term Dis..:

Lakatos, Peter L. ; Golovics, Petra A. ; Vegh, Zsuzsanna...
Gastroenterology. 148 (2015) 4 - p. S-243 , 2015

Link: https://doi.org/10.1016/..

12

Risk Matrix for Prediction of Disease Progression in a Refe..:

Lakatos, Peter L. ; Sipeki, Nora ; Kovacs, Gyorgy...
Journal of Crohn's and Colitis. 9 (2015) 10 - p. 891-898 , 2015

Link: https://doi.org/10.1093/..

13

Sa1168 Are Extraintestinal Manifestations Associated With D..:

Lovasz, Barbara D. ; Golovics, Petra A. ; Vegh, Zsuzsanna...
Gastroenterology. 148 (2015) 4 - p. S-246 , 2015

Link: https://doi.org/10.1016/..

14

Sa1169 Are Extraintestinal Manifestations Associated With D..:

Golovics, Petra A. ; Lovasz, Barbara D. ; Vegh, Zsuzsanna...
Gastroenterology. 148 (2015) 4 - p. S-246-S-247 , 2015

Link: https://doi.org/10.1016/..

15

Tu1348 Biosimilar Infliximab in Inflammatory Bowel Diseases..:

Gecse, Krisztina ; Farkas, Klaudia ; Lovasz, Barbara D....
Gastroenterology. 148 (2015) 4 - p. S-865-S-866 , 2015

Link: https://doi.org/10.1016/..